Anti-Rotavirus antibodies are immunoglobulins that specifically recognize and bind rotavirus, a double-stranded RNA virus and leading cause of severe gastroenteritis in infants and young children. In research applications, these antibodies are used to detect rotavirus antigens in infected cell lysates, cultured cells, and tissue samples. Rotavirus replicates within cytoplasmic viroplasms, membraneless organelles that concentrate the machinery needed for viral RNA synthesis and particle assembly. Detecting rotavirus antigens supports research into viral replication, host-virus interactions, and vaccine development.
Catalog highlights and purchasing considerations
About the Biocompare Rotavirus antibody catalog
The Biocompare antibody search tool lists anti-Rotavirus antibodies from a range of suppliers, available in unconjugated and fluorophore- or enzyme-conjugated formats. The listing may also include antibodies against specific rotavirus capsid proteins, such as VP6, VP4, and VP7. ELISA is the most common validated application among these listings, followed by western blot and immunofluorescence. Several Rotavirus antibodies mentioned here have been cited across a range of virology research, including NSP5-mediated hijacking of host ATP citrate lyase to support viral lipid biosynthesis, NCOA4-mediated ferritinophagy driving ferroptosis during infection, and signal peptidase complex involvement in VP7 processing and virion assembly.
Considerations when choosing a Rotavirus antibody for research
Confirm that the antibody's intended target is accurate, as many genes carry synonym symbols that can create ambiguity across suppliers. Specificity should be verified against the immunogen sequence or region listed on the product datasheet, since antibodies raised against different epitopes of the same protein can behave differently across applications. Beyond specificity, several target-related attributes can affect antibody binding, including subcellular location, extracellular and cytoplasmic domain boundaries for membrane-associated targets, tissue specificity, post-translational modifications, and the presence of additional isoforms or disease-associated variants. In parallel, antibody-specific selection criteria warrant consideration, including clonality (monoclonal versus polyclonal), host species, species reactivity, and conjugate or label choice suited to the detection method. Supplier validation data, such as western blot bands at the expected molecular weight, immunohistochemistry staining patterns consistent with known tissue distribution, and knockout or knockdown controls, should also be carefully reviewed before purchase.